Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 12:38 AM UTC
| NCT Number | NCT05640271 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Chicago |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of September 1, 2026: Clinical trial NCT05640271 is currently recruiting participants. This phase2 study for sickle cell disease is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05640271 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05640271 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.